Results 251 to 260 of about 9,625,606 (401)
Responses of the Normal Human to Infusions of Plasma from Patients with Graves\u27 Disease [PDF]
Arnaud, Claude D.+4 more
core +1 more source
A modular macroscopic supramolecular assembly is developed to prepare 3D bioactive structures with self‐sorting of two primary vascular cells in post‐adhesion based on orthogonally affinitive peptides, thus minimizing the compromise in structuring and cell viability.
Yuchen Liu+9 more
wiley +1 more source
Oscillation between Hyperthyroidism and Hypothyroidism in an Adolescent Female with Graves' Disease. [PDF]
Lee YL.
europepmc +1 more source
The release of COL6A3 by fibroblasts is sensed by the CD44 receptor on melanocytes, activating glutathione (GSH) metabolism and increasing melanocyte survival during skin organoid culture. SEMA3C released by bulge cells binds to the NRP1 receptor on melanocytes, regulating microtubule stability and promoting melanocyte recruitment and function during ...
Tingting Li+17 more
wiley +1 more source
Rare Autoimmune Pancytopenia Due to Graves Disease. [PDF]
Wang AW, Mahajan G, Etra A, Saul SR.
europepmc +1 more source
Dexamethasone Suppression Tests in Graves' Disease [Abridged]
I. C. Gilliland, Manjushree Ghose
openalex +1 more source
The NLR protein PibH8 interacts with phenylalanine ammonia‐lyase OsPAL1 and E3 ubiquitin ligase OsFBK16. Through competitive binding, PibH8 weakens the interaction between OsFBK16 and OsPAL1, thereby reducing the degradation of OsPAL1 by OsFBK16. The Hap1 allele of PibH8 exhibits a higher expression level than Hap2, thus accumulating more PibH8 protein,
Denghao Xiang+17 more
wiley +1 more source
Graves' Disease: Is It Time for Targeted Therapy? A Narrative Review. [PDF]
Viola N+5 more
europepmc +1 more source
A Case Report of Localized Myxedema in Graves' Disease
Hajime Ogura+5 more
openalex +2 more sources
USP45 Represses Melanoma Development by Deubiquitinating and Stabilizing Tumor Suppressor MRGPRF
USP45 acts as a melanoma suppressor by stabilizing MRGPRF, which weakens the PI3K/AKT pathway, suppresses tumor growth, and reduces melanoma cell migration and invasion. Abstract Melanoma, a highly malignant skin cancer, has seen a rising incidence and death toll. MRGPRF is a novel melanoma suppressor that inhibits the PI3K/AKT pathway.
Wancong Zhang+10 more
wiley +1 more source